Literature DB >> 7605985

Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice.

B P Sorrentino1, K T McDonagh, D Woods, D Orlic.   

Abstract

Transfer of the human multidrug resistance 1 (MDR1) gene to hematopoietic stem cells offers an approach to overcome the myelosuppression caused by a number of antineoplastic drugs. This study was designed to determine the effect of MDR1 gene transfer on overall P-glycoprotein (P-gp) expression in murine hematopoietic cells. Mice were transplanted with bone marrow cells infected with either of two different MDR1 retroviral vectors. A reverse-transcriptase polymerase chain reaction-based assay was used to quantify expression levels of both endogenous and vector-derived P-gp encoding transcripts in hematopoietic cells of transplanted mice. Expression of both a truncated and full-length MDR1 mRNA species was noted in bone marrow and spleen colony cells. The truncated message resulted from cryptic mRNA splice sites within the MDR1 cDNA and was detected with both vectors. Full-length message levels exceeded those from the endogenous genes in all but one case and roughly approximated that seen in the modestly drug-resistant cell line SW620. We conclude that transfer of MDR1 retroviral vectors resulted in a significant increase in P-gp expression in most cases; however, aberrant splicing of MDR1 transcripts can result in reduced expression of vector-derived P-gp.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605985

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo.

Authors:  Sheng Zhou; John J Morris; Yuxiao Barnes; Lubin Lan; John D Schuetz; Brian P Sorrentino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

Review 2.  Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy.

Authors:  Murtaza S Nagree; Lucía López-Vásquez; Jeffrey A Medin
Journal:  World J Stem Cells       Date:  2015-12-26       Impact factor: 5.326

3.  Harnessing Hematopoietic Stem Cell Low Intracellular Calcium Improves Their Maintenance In Vitro.

Authors:  Larry L Luchsinger; Alexandros Strikoudis; Nichole M Danzl; Erin C Bush; Michael O Finlayson; Prakash Satwani; Megan Sykes; Masayuki Yazawa; Hans-Willem Snoeck
Journal:  Cell Stem Cell       Date:  2019-06-06       Impact factor: 24.633

4.  Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model.

Authors:  Soghra Fatima; Sheng Zhou; Brian P Sorrentino
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

5.  Identification and characterization of a human tRNA-specific adenosine deaminase related to the ADAR family of pre-mRNA editing enzymes.

Authors:  S Maas; A P Gerber; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction.

Authors:  D Orlic; L J Girard; C T Jordan; S M Anderson; A P Cline; D M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Dye-Independent Methods Reveal Elevated Mitochondrial Mass in Hematopoietic Stem Cells.

Authors:  Mariana Justino de Almeida; Larry L Luchsinger; David J Corrigan; Linda J Williams; Hans-Willem Snoeck
Journal:  Cell Stem Cell       Date:  2017-11-30       Impact factor: 24.633

8.  Instability of retroviral vectors with HIV-1-specific RT aptamers due to cryptic splice sites in the U6 promoter.

Authors:  Stephen E Braun; Xuanling Shi; Gang Qiu; Fay Eng Wong; Pheroze J Joshi; Vinayaka R Prasad; R Paul Johnson
Journal:  AIDS Res Ther       Date:  2007-10-17       Impact factor: 2.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.